Elevated IL-6 and TNF-α levels in patients with ALS: Inflammation or hypoxia?

Neurology

Volumn 65, Issue 12, 2005, Pages 1958-1960

  Moreau, C ^a   Devos, D ^a   Brunaud Danel, V ^a   Defebvre, L ^a   Perez, T ^a   Destee A ^a   Tonnel, A B ^a   Lassalle, P ^a   Just, N ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOXEMIA; HYPOXIA; INFLAMMATION; MALE; MEDIATOR RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ANOXIA; BLOOD; BREATHING MUSCLE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; IMMUNOLOGY; MICROGLIA; MIDDLE AGED; MYELITIS; OXIDATIVE STRESS; PATHOLOGY; PREDICTION AND FORECASTING; RESPIRATORY FAILURE; UPREGULATION;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANOXIA; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MICROGLIA; MIDDLE AGED; MYELITIS; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MUSCLES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33645747484     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000188907.97339.76     Document Type: Article

References (10)

1. Weydt P, Huen EC, Ransom BR, et al. Increased cytotoxic potential of microglia from ALS transgenic mice. Glia 2004;48:179-82.
2. Ford L, Rowe D. IL 12 and IF γ are not detectable in the CSF of patients with ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:118-120.
3. Sekizawa T, Openshaw H, Ohbo K, et al. Cerebrospinal fluid IL-6 in ALS: immunological parameter and comparison with inflammatory and non inflammatory CNS disease. J Neurosci 1998;154:194-199.
4. Lyall RA, Donaldson N, Polkey MI, et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001;124:2000-2013.
5. Alberti A, Sarchielli P, Gallinella E, et al. Plasma cytokine levels in patients with sleep obstructive apnea syndrome: a preliminary study. J Sleep Res 2003;12:305-311.
6. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001;28:131-8.
7. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2002;1497:1-10.
8. Ali C, Nicole O, Docagne F, et al. Ischemia induced IL-6 as a potential endogenous neuroprotective cytokine against NMDA receptor mediated excitotoxicity in the brain. J Cereb Blood Flow Metab 2000;20:956-966.
9. Bilak M, Wu L, Wang Q, et al. PGE2 receptor rescue motor neurons in a model of ALS. Ann Neurol 2004;56:240-248.
10. Yasojima K, Tourtelotte W, Mc Geer E, et al. Marked increase in COX-2 in ALS spinal cords, implication for therapy. Neurology 2001;57:952-956.